September 10, 2019 Esmo 2019 preview – immunotherapies grab the rest of the late-breaker focus Away from the main small-molecule focus of this year’s Esmo meeting, Keytruda flies the flag for immuno-oncology, including in a little-noticed mesothelioma study.
